Samsung Medical Center

Public research footprint of Samsung Medical Center, compiled from the ClinicalTrials.gov public registry.

2,959

Registered studies

932

Active

520

Recruiting now

1,356

Completed

272

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Acute Myeloid Leukemia · Colitis, Ulcerative

Recently updated registry entries

NCT07586202 — A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants… (Recruiting)
NCT07581002 — A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV)… (Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Samsung Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.